An ingestible sensor for measuring medication adherence

IEEE Transactions on Biomedical Engineering

Volumn 62, Issue 1, 2015, Pages 99-109

  Hafezi, Hooman ^a   Robertson, Timothy L ^a   Moon, Greg D ^a   Au Yeung, Kit Yee ^a   Zdeblick, Mark J ^a   Savage, George M ^a  

^a Proteus Digital Health ^*  (United States)

Author keywords

Electrochemical devices; galvanic coupling; gastrointestinal fluid; human body tissues; intra body networks; pharmaceutical adherence; sensor; wireless communication

Indexed keywords

SAFETY TESTING; SENSORS; WIRELESS TELECOMMUNICATION SYSTEMS;

BODY NETWORKS; ELECTROCHEMICAL DEVICES; GALVANIC COUPLING; HUMAN BODY TISSUES; WIRELESS COMMUNICATIONS;

WIRELESS SENSOR NETWORKS;

ARTICLE; BODY FLUID; CHEMICAL SAFETY; DEVICE SAFETY; HUMAN; IN VITRO STUDY; INGESTIBLE SENSOR; INGESTION; INTEGRATED CIRCUIT; MECHANICS; MEDICATION COMPLIANCE; MICROTECHNOLOGY; NONHUMAN; PROTEUS; SENSOR; STATIC ELECTRICITY; TOXICITY TESTING; AMBULATORY MONITORING; ANALYSIS; ANIMAL; CHEMISTRY; CONDUCTOMETRY; DEVICE FAILURE ANALYSIS; DEVICES; DOG; DRUG MONITORING; EATING; ENTERIC COATED TABLET; EQUIPMENT DESIGN; ORAL DRUG ADMINISTRATION; PH; STOMACH JUICE; TRANSDUCER; WIRELESS COMMUNICATION;

DRUG; ENTERIC COATED TABLET;

ADMINISTRATION, ORAL; ANIMALS; CONDUCTOMETRY; DOGS; DRUG MONITORING; EATING; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; GASTROINTESTINAL CONTENTS; HUMANS; HYDROGEN-ION CONCENTRATION; MEDICATION ADHERENCE; MONITORING, AMBULATORY; PHARMACEUTICAL PREPARATIONS; TABLETS, ENTERIC-COATED; TRANSDUCERS; WIRELESS TECHNOLOGY;

EID: 84919941497     PISSN: 00189294     EISSN: 15582531     Source Type: Journal    
DOI: 10.1109/TBME.2014.2341272     Document Type: Article

References (38)

1. L.Osterberg and T. Blaschke, "Adherence tomedication," N. Eng. J. Med., vol. 353, no. 5, pp. 487-497, 2005.
2. "Thinking outside the pillbox: A system-wide approach to improving patient medication adherence for chronic disease," New England Healthcare Institute, Cambridge, MA, USA, 2009.
3. K. Nasseh, S. G. Frazee, J. Visaria, A. Vlahiotis, and Y. Tian, "Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia," Amer. J. Pharmacy Benefits, vol. 4, no. 2, pp. 41-47, 2010.
4. J. N. Rasmussen, A. Chong, and D. A. Alter, "Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction," J. Amer. Med. Assoc., vol. 297, no. 2, pp. 177-186, 2007.
5. R. Balkrishnan, "The importance of medication adherence in improving chronic disease-related outcomes: What we know and what we need to know further," Med Care, vol. 43, no. 5, pp. 517-520, 2005.
6. "The use of medicines in the united states : Review of 2011," IMS Institute for HEalth Informatics, Parsippany, NJ, USA, 2012.
7. Evaluation of automatic class III designation (de Novo) for Proteus Personal Monitor Including Ingestion Event Marker-K113070. Food and Drug Administration Health, Center for Device and Radiological Health, 2012.
8. D. Linden and T. B. Reddy, Handbook of Batteries, 3rd ed. New York, NY, USA: McGraw-Hill, 2001.
9. F. Sammoura, K. B. Lee, and L. Lin, "Water-activated disposable and long shelf life microbatteries," Sens. Actuators A, Phys., vol. 111, no. 1, pp. 79-86, Mar. 2004.
10. A. Heller, "Potentially implantable miniature batteries," Anal. Bioanal. Chem., vol. 385, pp. 469-473, 2006.
11. H. Jimbo and N. Miki, "Gastric-fluid-utilizing micro battery for micro medical devices," Sens. Actuators B, Chem., vol. 134, no. 1, pp. 219-224, Aug. 2008.
12. E. Frank, "Electric potential produced by two point current sources in a homogeneous conducting sphere," J. Appl. Phys., vol. 23, no. 11, pp. 1225-1228, 1952.
13. S. Rush and D. Driscoll, "EEG electrode sensitivity-An application of reciprocity," IEEE Trans. Biomed. Eng., vol. 16, no. 1, pp. 15-22, Jan. 1969.
14. Biological Evaluation of Medical Devices-Part 12: Sample Preparation and Reference Materials, vol. 12. International Organization for Standardization ISO 10993-12, 2007.
15. K. Y. Au-Yeung, G. D. Moon, T. L. Robertson, L. A. Dicarlo, M. S. Epstein, S. E. Weis, R. R. Reves, and G. Engel, "Early clinical experience with networked system for promoting patient self-management," Amer. J. Managed Care, vol. 17, no. 7, pp. e277-e287, Jan. 2011.
16. S. J. Watson, R. H. Smallwood, B. H. Brown, P. Cherian, and K. D. Bardhan, "Determination of the relationship between the pH and conductivity of gastric juice," Physiological Meas., vol. 17, no. 1, pp. 21-27, Feb. 1996.
17. F.Kong and R. P. Singh, "Disintegration of solid foods in human stomach," J. Food Sci., vol. 73, no. 5, pp. R67-R80, Jun. 2008.
18. M. Vertzoni, J. Dressman, J. Butler, J. Hempenstall, and C. Reppas, "Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds," Eur. J. Pharmaceutics Biopharmaceutics, vol. 60, no. 3, pp. 413-417, Aug. 2005.
19. A. Lindahl, A. Ungell, L. Knutson, and H. Lennernas, "Characterization of fluids from the stomach and proximal jejunum in men and women," Pharmaceutical Res., vol. 14, no. 4, pp. 497-502, 1997.
20. M. Feldman and C. Barnett, "Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn," Gastroenterology, vol. 108, no. 1, pp. 125-131, Jan. 1995.
21. B. Büttel, M. Fuchs, and B. Holz, "Freezing point osmometry of milk to determine the additional water content-an issue in general quality control and German food regulation," Chem. Central J., vol. 2, pp. 6-12, Jan. 2008.
22. C. Ramon, Y. Wang, J. Haueisen, P. Schimpf, S. Jaruvatanadilok, and A. Ishimaru, "Effect of myocardial anisotropy on the torso current flow patterns, potentials and magnetic fields," Phys. Med. Biol., vol. 45, pp. 1141-1150, 2000.
23. Guidance for Industry-Q3A Impurities in New Drug Substances. Silver Spring, MD, USA: Food and Drug Administration, 2008.
24. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC, USA: National Academy Press, 2001.
25. Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC, USA: National Academy Press, 1997.
26. WHO Food Additive Series 44-Safety Evaluation of Certain Food Additives and Contaminants. Geneva, Switzerland: WHO, 2000.
27. Thirty Fifth report of the joint FAO/WHO Expert Committee on Food Additives-Evaluation of certain food additives and contaminants. Geneva, Switzerland: WHO Press, 1990.
28. T. Kararli, "Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals," Biopharmaceutics Drug Disposition, vol. 16, pp. 351-380, 1995.
29. R. Khosla and S. S.Davis, "The effect of tablet size on the gastric emptying of non-disintegrating tablets," Int. J. Pharmaceutics, vol. 62, no. 2-3, pp. R9-R11, Jul. 1990.
30. D. A. Adkin, S. S. Davisa, R. A. Sparrow, and I. R. Wildingb, "Colonic transit of different sized tablets in healthy subjects," J. Controlled Release, vol. 23, pp. 147-156, 1993.
31. L. Geddes, "Chronaxie," Australas. Phys. Eng. Sci. Med., vol. 22, no. 1, pp. 13-17, 1999.
32. L. Geddes, "Accuracy limitations of chronaxie values," IEEE Trans. Biomed. Eng., vol. 51, no. 1, pp. 176-181, Jan. 2004.
33. J. Zhang and J. D. Z. Chen, "Systematic review: Applications and future of gastric electrical stimulation," Alimentary Pharmacology Therapeutics, vol. 24, no. 7, pp. 991-1002, Oct. 2006.
34. G. Song, X. Hou, B. Yang, Y. Sun, J. Liu, W. Qian, and J. D. Z. Chen, "Efficacy and efficiency of gastric electrical stimulation with short pulses in the treatment of vasopressin-induced emetic responses in dogs," Neurogastroenterology Motility, vol. 18, no. 5, pp. 385-391, May 2006.
35. A. Arriagada, A. S. Jurkov, E. Neshev, G. Muench, M. P. Mintchev, and C. N. Andrews, "Comparative gastric motility study of enterraTM therapy and neural gastric electrical stimulation in an acute caninemodel," Neurogastroenterology Motility, vol. 23, no. 3, pp. 271-278, Mar. 2011.
36. T. Litovitz, N. Whitaker, and L. Clark, "Preventing battery ingestions: An analysis of 8648 cases," Pediatrics, vol. 125, no. 6, pp. 1178-1183, Jun. 2010.
37. K. Y. Au-Yeung, T. Robertson, H. Hafezi, G. Moon, L. DiCarlo, M. Zdeblick, and G. Savage, "A networked system for self-management of drug therapy and wellness," in Proc. Wireless Health Conf., 2010, pp. 1-9.
38. L. DiCarlo, G. Moon, A. Intondi, R. Duck, J. Frank, H. Hafazi, Y. Behzadi, T. Robertson, B. Costello, G. Savage, and M. Zdeblick, "A digital health solution for using and managing medications," IEEE Pulse, vol. 3, no. 5, pp. 23-26, Sep. 2012.